SCOVERNLAW

Terry Turner, Drugwatch The number of people taking the gout medication allopurinol has been rising as gout becomes more prevalent. Prescriptions also got a boost after the U.S. Food and Drug Administration limited the use of Uloric (febuxostat) in 2019, effectively leaving allopurinol as the primary first-line medication option for gout patients. But at the […]

It is necessary to continue urate-lowering therapy in the inpatient setting to decrease the risk of gout flare in hospitalized patients.   Gout flare is almost 14-times more likely to develop in hospitalized patients who have allopurinol discontinued upon admission compared to those who have the treatment continued, according to new study findings. The findings, presented […]